Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biohaven Ltd (NY: BHVN ) 47.99 -0.58 (-1.19%) Official Closing Price Updated: 4:10 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biohaven Ltd < Previous 1 2 3 4 5 6 7 8 9 Next > Acuity Brands, Nike And 3 Stocks To Watch Heading Into Tuesday October 01, 2024 Via Benzinga Hewlett Packard Enterprise, Nvidia, Progress Software And Other Big Stocks Moving Higher On Wednesday September 25, 2024 Via Benzinga Biohaven Stock Soars on Drug Trial Results: Time to Jump In? September 24, 2024 Biohaven, a clinical-stage biopharmaceutical company, is attracting investors with promising results for its experimental drug. Via MarketBeat Dow Gains Over 50 Points; Elevai Labs Shares Plummet September 23, 2024 Via Benzinga Topics Stocks Exposures US Equities 10 Health Care Stocks With Whale Alerts In Today's Session September 23, 2024 Via Benzinga BHVN Stock Earnings: Biohaven Misses EPS for Q2 2024 August 09, 2024 BHVN stock results show that Biohaven missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace BHVN Stock Earnings: Biohaven Misses EPS for Q1 2024 May 09, 2024 BHVN stock results show that Biohaven missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Crude Oil Down Over 1%; US Manufacturing PMI Falls In September September 23, 2024 Via Benzinga Exposures Fossil Fuels Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise September 23, 2024 Biohaven announced topline results from its pivotal Study BHV4157-206-RWE, showing that troriluzole significantly slowed disease progression in spinocerebellar ataxia patients over three years. The... Via Benzinga Exposures Product Safety Biohaven, Tesla And Other Big Stocks Moving Higher On Monday September 23, 2024 Via Benzinga Biohaven Surges After Delaying Progression By Up To 70% In A Rare Disease September 23, 2024 The company is hoping to soon file for approval of what could be the first SCA treatment. Via Investor's Business Daily This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday September 16, 2024 Via Benzinga Biohaven Stock Earns Relative Strength Rating Upgrade August 21, 2024 Biohaven stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 88 to 91. Via Investor's Business Daily $1M Bet On Biohaven? Check Out These 3 Stocks Insiders Are Buying July 22, 2024 Via Benzinga The 3 Smartest Healthcare Stocks to Buy With $1K Right Now June 28, 2024 The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector. Via InvestorPlace HP Posts Upbeat Earnings, Joins Foot Locker, American Superconductor, Red Robin Gourmet Burgers And Other Big Stocks Moving Higher On Thursday May 30, 2024 Via Benzinga After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay May 30, 2024 Immunovant, which jumped Wednesday on news from rival Biohaven, reversed course Thursday. Via Investor's Business Daily Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study May 29, 2024 Biohaven shares drop as interim data from the Phase 1 study of BHV-1300 fell short of investor expectations. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 29, 2024 Via Benzinga What's Going On With Biohaven Stock Wednesday? May 29, 2024 The company announced it dosed a patient with a new possible treatment for certain cancers, showcased positive data from two different studies and presented other updates. Via Benzinga Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump May 29, 2024 The company says it's still running additional testing of the drug, calling the results "positive." Via Investor's Business Daily 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 29, 2024 Via Benzinga This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan May 21, 2024 The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential. Via Benzinga Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday May 14, 2024 Via Benzinga Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday May 13, 2024 Via Benzinga Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar May 01, 2024 These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May. Via InvestorPlace Around $1M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying April 26, 2024 Via Benzinga 3 Biotech Stocks to Buy on the Dip: April 2024 April 26, 2024 With medical innovation being a resilient space, investors can have confidence with these biotech stocks to buy on the dip. Via InvestorPlace Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday? March 27, 2024 Latest findings on Altimmune's pemvidutide on body composition: lean mass preservation, significant weight loss from adipose tissue, and results in obesity and Metabolic dysfunction-associated... Via Benzinga Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 15, 2024 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.